A

AdvanCell Isotopes Pty Ltd

17 employees

AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Clinical Applications
Chelation Chemistry
Pharmaceutical
Nuclear Materials
Clinical Trials
Theranostics

Date founded

2019

Funding rounds raised

Total raised

$12M

from 2 investors over 2 rounds

A

AdvanCell Isotopes Pty Ltd raised $12M on August 23, 2022

Investors: Morningside Venture Capital 晨兴资本

A

AdvanCell Isotopes Pty Ltd raised $2.1M on December 23, 2021

Investors: NSW Health

FAQ